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Introduction
• Use of antiplatelet/anticoagulant drugs is very common
in elderly patients, particularly aspirin
• In head trauma aspirin use increases risk of traumatic
brain injury (TBI)
• Accurate medication history is important for rapid
implementation of anticoagulant/antiplatelet reversal
protocols
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Study Aim:

Determine what proportion of TBI
patients without antiplatelet
medications in their history show
signs of antiplatelet use on
laboratory testing
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Anticoagulant/Antiplatelet Medications

• Common Anticoagulants: Heparin, Warfarin, Apixaban,
etc.
– Interfere with clotting factors
• Common Antiplatelets: Aspirin, Clopidogrel, Prasugrel,
etc.
– Interfere with platelet function
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Aspirin
• Acetylsalicylic Acid (ASA)
• Prescription or over-the-counter
• Part of many over the counter
compounds (Alka Seltzer, Goody’s
Powder, BC Powder, etc.)
• COX-2 inhibitor
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TBI in the elderly
• Falls, MVC’s, Struck By Object leading
causes of TBI
• Almost ½ of trauma patients at GSMC
each year present for falls, majority 60+
• Highest rate of TBI deaths in patients
75+
• Anticoagulant/antiplatelet use increases
risk of TBI
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Rotational Thromboelastometry
(ROTEM)
• Viscoelastic hemostasis test
• Provides information on clotting time, clot firmness, time
to lysis, etc.
• Rotating sensor is placed in blood sample, measures
elasticity and plots amplitude over time
• Types of ROTEM: EXTEM, INTEM, FIBTEM, APTEM
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Reading ROTEM results
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Methods
• Deidentified, retrospective review
• Data obtained from Enterprise Data Warehouse
• Grand Strand Medical Center (GSMC) data only
• Patients categorized based on medication history, type
of TBI, ROTEM results, VerifyNow Aspirin results,
plateletpheresis status
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1.1 Overview

Inclusion & Exclusion Criteria:
Inclusion:

Exclusion:

• Trauma Patient at GSMC

• No Home Meds listed

• Between September 1,
2017 – May 30, 2019

• No GCS score
• No ROTEM results listed

• 65 years or older
• Dx with TBI
491 total patients
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168 Patients
Included in Study

Antiplatelet ROTEM Criteria
EITHER:
• MCF EXTEM < 50 mm AND MCF FIBTEM
≥ 10 mm
• MCF EXTEM < 50 mm or A10 EXTEM < 40
mm AND no FIBTEM results
• CFT EXTEM > 160 s AND CFT APTEM <
160 s
• A10 INTEM < 35 mm
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Results
Table 1. Demographic Characteristics of Study Participants (N=168)
Mean (SD)
Age
Total GCS
13.6(3.2)
Sex
Male
Female
Mode of Injury (MOI)
Fall
Other MOI
Patient Self Report of Aspirin History
Yes Aspirin History
No Aspirin History
Patient Self Report of Other Anticoag
Yes Anticoag History
No Anticoag History
ROTEM Test
Indicates Antiplatelet Use
Does not Indicate Antiplatelet Use

Min
65
3

Max
>90
15

Frequency

Percentage

84
84

50.0
50.0

130
38

77.4
22.6

76
92

45.2
54.8

76
92

45.2
54.8

4
164

2.4
97.6
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Results
Table 2. Demographic Characteristics of Study Participants with No History of ASA and No History of
Other Anticoag (N=50)
Mean (SD)
Min
Max
Age
65
>90
Total GCS
12.4(4.6)
3
15
Sex
Male
Female
Mode of Injury (MOI)
Fall
Other MOI
ROTEM Test
Indicates Antiplatelet Use
Does not Indicate Antiplatelet Use

Frequency

Percentage

21
29

42.0
58.0

34
16
3
2
48

68.0
32.0
8.57
4.0
96.0

This research was supported (in whole or in part) by HCA and/or an HCA affiliated entity. The views expressed in this
13
publication represent those of the author(s) do not necessarily represent the official views of HCA or any of its affiliated entities.

Results
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Results
METHOD OF INJURY LEADING TO TBI

22.6%
Fall
Other MOI

77.4%
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Results
Table 3. Results of Chi-squared and Fisher Exact Test Statistical Analysis
Positive ROTEM
Positive ROTEM ASA
Other Anti Coag
1 (76)
1 (76)
Positive ROTEM ASA vs Other
Positive ROTEM ASA vs None
Gender of Population with
Antiplatelet/Anticoagulant vs None
Method of Injury in Population with
Antiplatelet/Anticoagulant vs None
Positive VerifyNow ASA vs Other
Positive VerifyNow ASA vs both ASA and Other
Positive VerifyNow ASA vs None
Positive VerifyNow ASA vs No ASA
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p-value
1
0.5622
0.177
0.0585
0.2636
0.493
0.4812
0.5913

Limitations
• Relatively small sample size
– ROTEM not performed as often as anticipated
• Confounding variables not explored (comorbidities,
PT/PTT, etc.)
• Ongoing project
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